体外診断（IVD）の世界市場：体外診断装置、体外診断試薬、体外診断ソフトウェア、サービス...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 31)
4.1 Growth Potential of the IVD Market
4.2 North America: IVD Market
4.3 IVD Market: Geographic Snapshot
4.4 Geographic Mix: IVD Market, By Technology
4.5 IVD Market: Emerging vs Developed Markets

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Segmentation
5.2.1 In Vitro Diagnostics Market, By Product
5.2.2 In Vitro Diagnostics Market, By Technology
5.2.3 In Vitro Diagnostics Market, By Application
5.2.4 In Vitro Diagnostics Market, By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Incidence of Chronic Lifestyle Diseases Across the Globe
5.3.1.2 Rapid Growth in the Geriatric Population
5.3.1.3 Increasing Adoption of Point-Of-Care (POC) Testing
5.3.1.4 Growing Awareness of Personalized Medicine
5.3.2 Restraints
5.3.2.1 Inadequate Reimbursement
5.3.2.2 Implementation of Excise Duty By the U.S. Government
5.3.3 Opportunities
5.3.3.1 New Range of Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
5.3.3.2 Emerging Economies With Increasing Investments
5.3.4 Challenges
5.3.4.1 Stringent Regulatory Framework

6 Industry Insights (Page No. – 48)
6.1 Introduction
6.2 Industry Trends
6.3 Porter’s Five Force Analysis
6.3.1 Threat From New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Regulatory Analysis
6.4.1 North America
6.4.1.1 U.S.
6.4.1.2 Canada
6.4.2 Europe
6.4.3 Asia-Pacific
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 India
6.4.3.4 Australia

7 Global IVD Market, By Product & Service (Page No. – 57)
7.1 Introduction
7.2 Reagents & Kits
7.3 Instruments
7.4 Data Management Software/Hardware
7.5 Services

8 Global IVD Market, By Technology (Page No. – 69)
8.1 Introduction
8.2 Clinical Chemistry
8.2.1 Basic Metabolic Panel
8.2.2 Electrolyte Panels
8.2.3 Liver Panels
8.2.4 Lipid Profiles
8.2.5 Renal Profiles
8.2.6 Thyroid Function Panels
8.2.7 Specialty Chemical Tests
8.3 Immunochemistry/Immunoassays
8.3.1 Elisa
8.3.1.1 Chemiluminescence Immunoassays (CLIAs)
8.3.1.2 Fluorescence Immunoassays (FIA)
8.3.1.3 Colorimetric Immunoassays (CI)
8.3.2 Radioimmunoassays (RIA)
8.3.3 Rapid Tests
8.3.4 Western Blot
8.3.5 Elispot
8.4 Hematology
8.5 Coagulation and Hemostasis
8.6 Microbiology
8.7 Molecular Diagnostics (MDX)
8.7.1 Polymerase Chain Reaction (PCR)
8.7.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.7.3 Microarrays
8.7.4 Hybridization
8.7.5 Dna Sequencing & Next-Generation Sequencing
8.7.6 Others
8.8 Others

9 In Vitro Diagnostics Market, By Application (Page No. – 121)
9.1 Introduction
9.2 Diabetes
9.3 Infectious Diseases
9.4 Oncology/Cancer
9.5 Cardiology
9.6 Nephrology
9.7 Autoimmune Diseases
9.8 Drug Testing
9.9 HIV/AIDS
9.1 Other Applications

10 Global IVD Market, By End User (Page No. – 141)
10.1 Introduction
10.2 Laboratories
10.3 Hospitals
10.4 Academic Institutes
10.5 Point-Of-Care Testing
10.6 Patient Self-Testing
10.7 Others

11 Geographic Analysis Key Findings (Page No. – 153)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Russia
11.3.7 Rest of Europe (RoE)
11.4 Asia-Pacific (APAC)
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.5 Rest of the World (RoW)
11.5.1 Latin America
11.5.1.1 Brazil
11.5.1.2 Mexico
11.5.1.3 Rest of Latin America (RoLA)
11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. – 230)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.4 New Product Launches
12.5 Agreements, Partnerships, and Collaborations
12.6 Mergers and Acquisitions
12.7 Expansions

13 Company Profiles (Page No. – 237)
13.1 Abbott Laboratories, Inc.
13.1.1 Business Overview
13.1.2 Products Offered
13.1.3 Services Offered
13.1.4 Recent Developments
13.1.5 MnM View
13.2 Roche Diagnostics
13.2.1 Business Overview
13.2.2 Products Offered
13.2.3 Recent Developments
13.2.4 MnM View
13.3 Biomérieux
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Recent Developments
13.4 Ortho Clinical Diagnostics, Inc.
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Services Offered
13.5.4 Recent Developments
13.6 Danaher Corporation
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Services Offered
13.6.4 Recent Developments
13.6.5 MnM View
13.7 Johnson and Johnson
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.7.4 MnM View
13.8 Siemens Healthcare
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Services Offered
13.8.4 Recent Developments
13.8.5 MnM View
13.9 Sysmex Corporation
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Services Offered
13.9.4 Recent Developments
13.10 Becton, Dickinson and Company
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Thermo Fisher Scientific, Inc.
13.11.1 Business Overview
13.11.2 Products Offered
13.11.3 Services Offered
13.11.4 Recent Developments

14 Appendix (Page No. – 296)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 O Ther Developments, 2012–2015
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports